Vaxil Provides Update on Preclinical Experiment
Not for distribution by US newswire or in United StatesThe Company is not making any express or implied claims that […]
Enlivex Selected by the Israel Innovation Authority to Receive $1.5 Million Grant to Fund COVID-19 and Sepsis Clinical Trials
Nes Ziona, Israel, April 13, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced […]
Champignon acquiert Altmed Capital Corp, la seule clinique de médecine psychédélique approuvée par santé canada, les sops pour une expansion clinique, les propriétés intellectuelles et les essais cliniques existants
VANCOUVER, Colombie-Britannique, 13 avr. 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTC : […]
TRHC Provides COVID-19 Testing Opportunities to Community Pharmacies Across the United States
MOORESTOWN, N.J., April 13, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the […]
Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia
TUSTIN, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing […]
SCWorx Announces First Installment of Purchase Order For 48 Million COVID-19 Rapid Testing Units Over Twenty-Four Weeks at $35 Million Dollars Per Week
NEW YORK, April 13, 2020 (GLOBE NEWSWIRE) — SCWorx Corp. (Nasdaq: WORX) announced today that it has received a committed […]
Viemed Healthcare Comments on Competitive Bidding
LAFAYETTE, La., April 13, 2020 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a […]
Shockwave Completes Enrollment of Coronary Intravascular Lithotripsy Study in Japan
SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of […]
Arcturus Therapeutics Announces Allowance of IND & Approval of Clinical Trial Application (CTA) for ARCT-810, a First-in-Class Investigational mRNA Medicine to Treat Ornithine Transcarbamylase Deficiency
Clinical Plan Includes Healthy Volunteers in New Zealand and OTC-Deficient Patients Across Several Sites in United StatesInvestor Conference Call at 4:00 […]
TSX News -
Patriot One Hires New Chief Operating Officer & President Dietmar Wennemer
TORONTO, April 13, 2020 (GLOBE NEWSWIRE) — Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the […]
